Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Ixekizumab has known and some unexpected side effects.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Ixekizumab effectively treats generalized pustular psoriasis.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Anti-CD19 therapy may help treat SLE and NMOSD.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Biologics for severe asthma have known side effects, but some new risks need more study.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Co-trimoxazole may help treat autoimmune diseases.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Pegvaliase is recommended for treating adults with phenylketonuria.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

New treatments for lupus show promise, but more research is needed, especially for children.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.